We’ve rebranded some of our products, learn more ›
CODEX is now PhenoCycler Phenoptics is now Phenolmager
Why Partner with Akoya Biosciences?
As inventors of the PhenoImager™ technology (formerly Phenoptics™), we leverage deep expertise in multiplex imaging and cutting-edge spatial technologies to design and develop your next-generation spatial biomarker assays. Our CLIA-certified lab provides a wide range of service offerings to meet your translational and clinical research needs.
Akoya’s Advanced Biopharma Solutions (ABS) is a premium service for biopharmaceutical companies who want to discover and develop actionable spatial biomarkers for their translational pathology and immunotherapy programs.
Custom Assay Development
Fit-for-purpose analytically validated panels to support RUO projects, trial enrollment, and clinical studies
Proprietary Image Analysis
Advanced tools and technical capabilities ensure the most accurate and reproducible data
CDx Assay Development
Comprehensive services for development of FDA-cleared diagnostics to support therapy decisions
Flexibility to Match Your Needs
Our multi-disciplinary team of experts can develop a customized work plan that encompasses your project’s every need, delivering information on time and on budget to help discover and validate spatial biomarkers needed to propel your research forward.
Akoya offers the most advanced and complete solution for multiplexed tissue analysis. Leverage our decades of expertise to support your tissue analysis needs.
Assay Design
Assay Design, Development and Validation
Sample Staining and QC
Sample Procurement
Sample Preparation
Pathology Review
Tissue Staining
Image Acquisition
Image Acquisition using PhenoImager platform
Analytics and Reporting
Image Analysis Algorithm Development and Validation
Image Interpretation and Analysis
Reporting
AstraZeneca and Akoya Collaboration
On Spatial Biology Approach to Profiling Tumor-Immune Biology
The partnership aims to leverage spatial biology data, generated on Akoya’s PhenoImager platform, to inform and guide drug development programs.
